Study of the Efficacy, Biodistribution, and Safety Profile of Therapeutic Gutless Adenovirus Vectors as a Prelude to a Phase I Clinical Trial for Glioblastoma

Designer Therapies for Glioblastoma Multiforme

(2009) Sith Sathornsumetee et al.   Annals of the New York Academy of Sciences

Antiglioma Immunological Memory in Response to Conditional Cytotoxic/Immune-Stimulatory Gene Therapy: Humoral and Cellular Immunity Lead to Tumor Regression

(2009) A.K.M. Ghulam Muhammad et al.   CLINICAL CANCER RESEARCH

Identifying the Safety Profile of Ad5.SSTR/TK.RGD, a Novel Infectivity-Enhanced Bicistronic Adenovirus, in Anticipation of a Phase I Clinical Trial in Patients with Recurrent Ovarian Cancer

(2009) K. Matthews et al.   CLINICAL CANCER RESEARCH

Release of HMGB1 in Response to Proapoptotic Glioma Killing Strategies: Efficacy and Neurotoxicity

(2009) M. Candolfi et al.   CLINICAL CANCER RESEARCH

Gene Therapy for Brain Cancer: Combination Therapies Provide Enhanced Efficacy and Safety

(2009) Marianela Candolfi et al.   CURRENT GENE THERAPY

A preclinical assessment of the safety and biodistribution of an adenoviral vector containing the herpes simplex virus thymidine kinase gene (Cerepro®) after intracerebral administration

(2009) Gillian Langford et al.   JOURNAL OF GENE MEDICINE

HMGB1 Mediates Endogenous TLR2 Activation and Brain Tumor Regression

(2009) James F Curtin et al.   PLOS MEDICINE

Frequently asked questions in the medical management of high-grade glioma: a short guide with practical answers

(2008) R. Stupp et al.   ANNALS OF ONCOLOGY

Biodistribution of an oncolytic adenovirus after intracranial injection in permissive animals: a comparative study of Syrian hamsters and cotton rats

(2008) A M Sonabend et al.   CANCER GENE THERAPY

Topotecan enhances immune clearance of gliomas

(2008) Jun Wei et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

High-Capacity Adenovirus Vector-Mediated Anti-Glioma Gene Therapy in the Presence of Systemic Antiadenovirus Immunity

(2008) G. D. King et al.   JOURNAL OF VIROLOGY

Flt3L in Combination With HSV1-TK-mediated Gene Therapy Reverses Brain Tumor–induced Behavioral Deficits

(2008) Gwendalyn D King et al.   MOLECULAR THERAPY

Malignant Gliomas in Adults

(2008) Patrick Y. Wen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Flt3L and TK gene therapy eradicate multifocal glioma in a syngeneic glioblastoma model

(2007) Gwendalyn D. King et al.   NEURO-ONCOLOGY